These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 35057704)
1. Discovery of new 1,4-disubstituted 1,2,3-triazoles: Şahin İ; Çeşme M; Yüce N; Tümer F J Biomol Struct Dyn; 2023 Mar; 41(5):1988-2001. PubMed ID: 35057704 [TBL] [Abstract][Full Text] [Related]
2. Triazole based novel molecules as potential therapeutic agents: Synthesis, characterization, biological evaluation, in-silico ADME profiling and molecular docking studies. Şahin İ; Çeşme M; Özgeriş FB; Tümer F Chem Biol Interact; 2023 Jan; 370():110312. PubMed ID: 36535312 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, spectroscopic characterization, single crystal X-ray analysis, in vitro α-amylase inhibition assay, DPPH free radical evaluation and computational studies of naphtho[2,3-d]imidazole-4,9-dione appended 1,2,3-triazoles. Devi M; Kumar P; Singh R; Sindhu J; Kataria R Eur J Med Chem; 2023 Mar; 250():115230. PubMed ID: 36863227 [TBL] [Abstract][Full Text] [Related]
4. Potent α-amylase inhibitors and radical (DPPH and ABTS) scavengers based on benzofuran-2-yl(phenyl)methanone derivatives: Syntheses, in vitro, kinetics, and in silico studies. Ali I; Rafique R; Khan KM; Chigurupati S; Ji X; Wadood A; Rehman AU; Salar U; Iqbal MS; Taha M; Perveen S; Ali B Bioorg Chem; 2020 Nov; 104():104238. PubMed ID: 32911195 [TBL] [Abstract][Full Text] [Related]
5. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives. Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866 [TBL] [Abstract][Full Text] [Related]
6. New Hybrid Hydrazinyl Thiazole Substituted Chromones: As Potential α-Amylase Inhibitors and Radical (DPPH & ABTS) Scavengers. Salar U; Khan KM; Chigurupati S; Taha M; Wadood A; Vijayabalan S; Ghufran M; Perveen S Sci Rep; 2017 Dec; 7(1):16980. PubMed ID: 29209017 [TBL] [Abstract][Full Text] [Related]
7. New sulfonamide derivatives based on 1,2,3-triazoles: synthesis, Şahin İ; Çeşme M; Güngör Ö; Özgeriş FB; Köse M; Tümer F J Biomol Struct Dyn; 2024 Jun; 42(9):4782-4799. PubMed ID: 37317998 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro α-amylase inhibitory, and radicals (DPPH & ABTS) scavenging potentials of new N-sulfonohydrazide substituted indazoles. Rafique R; Khan KM; Arshia ; Chigurupati S; Wadood A; Rehman AU; Salar U; Venugopal V; Shamim S; Taha M; Perveen S Bioorg Chem; 2020 Jan; 94():103410. PubMed ID: 31732193 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship, Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 2,6-di(substituted phenyl)thiazolo[3,2-b]-1,2,4-triazoles as α-glucosidase and α-amylase inhibitors, co-relative Pharmacokinetics and 3D QSAR and risk analysis. Channar PA; Saeed A; Larik FA; Rashid S; Iqbal Q; Rozi M; Younis S; Mahar J Biomed Pharmacother; 2017 Oct; 94():499-513. PubMed ID: 28780468 [TBL] [Abstract][Full Text] [Related]
11. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies. Rostom SAF; Badr MH; Abd El Razik HA; Ashour HMA Eur J Med Chem; 2017 Oct; 139():263-279. PubMed ID: 28803043 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of thiazolidine-2,4-dione tethered 1,2,3-triazoles as α-amylase inhibitors: In vitro approach coupled with QSAR, molecular docking, molecular dynamics and ADMET studies. Singh R; Sindhu J; Devi M; Kumar P; Lal S; Kumar A; Singh D; Kumar H Eur J Med Chem; 2024 Sep; 275():116623. PubMed ID: 38943875 [TBL] [Abstract][Full Text] [Related]
13. Syntheses, in vitro, and in silico studies of rhodanine-based schiff bases as potential α-amylase inhibitors and radicals (DPPH and ABTS) scavengers. Egu SA; Ali I; Khan KM; Chigurupati S; Qureshi U; Salar U; Taha M; Felemban SG; Venugopal V; Ul-Haq Z Mol Divers; 2023 Apr; 27(2):767-791. PubMed ID: 35604512 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies. Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061 [TBL] [Abstract][Full Text] [Related]
15. New Hybrid Scaffolds based on Hydrazinyl Thiazole Substituted Coumarin; As Novel Leads of Dual Potential; In Vitro α-Amylase Inhibitory and Antioxidant (DPPH and ABTS Radical Scavenging) Activities. Salar U; Khan KM; Chigurupati S; Syed S; Vijayabalan S; Wadood A; Riaz M; Ghufran M; Perveen S Med Chem; 2019; 15(1):87-101. PubMed ID: 30179139 [TBL] [Abstract][Full Text] [Related]
16. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents. Fettach S; Thari FZ; Hafidi Z; Karrouchi K; Bouathmany K; Cherrah Y; El Achouri M; Benbacer L; El Mzibri M; Sefrioui H; Bougrin K; Faouzi MEA J Biomol Struct Dyn; 2023 Feb; 41(3):1072-1084. PubMed ID: 34957934 [TBL] [Abstract][Full Text] [Related]
17. Rational design of 1,2,3-triazole hybrid structures as novel anticancer agents: synthesis, biological evaluation and molecular docking studies. Çot A; Çeşme M; Onur S; Aksakal E; Şahin İ; Tümer F J Biomol Struct Dyn; 2023; 41(14):6857-6865. PubMed ID: 35983627 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in silico studies of fluorinated 2,3-disubstituted thiazolidinone-pyrazoles as potential α-amylase inhibitors and antioxidant agents. Ganavi D; Ramu R; Kumar V; Patil SM; Martiz RM; Shirahatti PS; Sathyanarayana R; Poojary B; Holla BS; Poojary V; Kumari KPN; Shivachandra JC Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100342. PubMed ID: 34923670 [TBL] [Abstract][Full Text] [Related]
19. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies. Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353 [TBL] [Abstract][Full Text] [Related]
20. Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Sayed HM; Ahmed AS; Khallaf IS; Qayed WS; Mohammed AF; Farghaly HSM; Asem A J Ethnopharmacol; 2023 Mar; 303():115938. PubMed ID: 36410572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]